rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ilan Oren

Director

Company insider

Files Form 4 as: Director, Roivant Sciences.

In numbers

Trades disclosed
47
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
20 Jul 2022
Last trade
16 Sep 2026
Last filed
18 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ROIV Roivant SciencesDirector · Biotechnology · last 16 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
16 Sep 2026filed 18 Sep 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—5,054 at $0.00filing
16 Sep 2026filed 18 Sep 2026ROIV Roivant Sciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,531 at $0.00filing
16 Sep 2026filed 18 Sep 2026ROIV Roivant Sciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,531 at $0.00filing
16 Sep 2026filed 18 Sep 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—5,054 at $0.00filing
10 Sep 2026filed 14 Sep 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$97K2,378 at $40.94filing
10 Sep 2026filed 14 Sep 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$97K2,378 at $40.94filing
17 Jul 2026filed 21 Jul 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—775 at $0.00filing
17 Jul 2026filed 21 Jul 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—775 at $0.00filing
17 Apr 2026filed 21 Apr 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—896 at $0.00filing
17 Apr 2026filed 21 Apr 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$2,83495 at $29.83filing
17 Apr 2026filed 21 Apr 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—896 at $0.00filing
17 Apr 2026filed 21 Apr 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$2,83495 at $29.83filing
20 Jan 2026filed 22 Jan 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—1,164 at $0.00filing
20 Jan 2026filed 22 Jan 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$2,850124 at $22.98filing
20 Jan 2026filed 22 Jan 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—1,164 at $0.00filing
20 Jan 2026filed 22 Jan 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$2,850124 at $22.98filing
20 Oct 2025filed 22 Oct 2025ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—1,507 at $0.00filing
20 Oct 2025filed 22 Oct 2025ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$4,985281 at $17.74filing
10 Sep 2025filed 12 Sep 2025ROIV Roivant Sciencesoption or derivative · BiotechnologySEC FORM 4 Code A—33,726 at $0.00filing
10 Sep 2025filed 12 Sep 2025ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—14,524 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Matthew GlineCEO · CEO at Roivant Sciences, filing Form 4 there in the last year
Mayukh SukhatmePresident & CIO · President & CIO at Roivant Sciences, filing Form 4 there in the last year
Epperly Melissa BDirector · Director at Roivant Sciences, filing Form 4 there in the last year
Frank TortiPresident and Vant Chair · President and Vant Chair at Roivant Sciences, filing Form 4 there in the last year
Eric VenkerChief Executive Officer · President & Immunovant CEO at Roivant Sciences, filing Form 4 there in the last year